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Summary
Introduction. — Transcatheter cryoablation is an alternative option for the treatment of
supraventricular tachycardia, due to its very low risk of permanent atrio-ventricular block.
However, the overcost of cryocatheter and the high recurrence rate of this emerging
technology braked its large use. This study reports the results of an approach using cryoablation
for the treatment of junctional tachycardia (JT) in selected patients at high risk of atrio-
ventricular (AV) block.
Patients and methods. — Out of a series of 199 patients with JT treated by catheter ablation,
26 benefited from cryoablation (mean age 32.8±15 years, 15 males). The indications were the
presence of an accessory pathway with a high risk of atrio-ventricular block (n=7), a slow
pathway difficult to ablate, with a risk of atrio-ventricular block (n=7), a recurrence after a RF
procedure, during which a transient atrio-ventricular block has occurred (n=4), and finally
patients at young age (n=8).
Results. — The primary success rate was 92%. No permanent AV block has been reported,
neither with RF nor with cryoablation. The recurrence rate at 9±10 months was at 29% after
cryoablation and 8.6% after RF. In case of AV nodal reentrant tachycardia, the additional cost
of cryotherapy catheter has been avoided in 76.85% of cases. The use of a cryotherapy catheter
and RF catheter has been necessary for the remaining cases.
Conclusion. — This study demonstrates that an approach, reserving cryoablation in selected
patients at high risk of AV block is an alternative strategy to “the systematic use” of
cryotherapy in the ablation of JT with a high efficacy, an excellent safety and a reduced cost.
© 2008 Published by Elsevier Masson SAS.
Résumé
Introduction. — Le très faible risque de bloc auriculo-ventriculaire permanent lors de la
cryoablation place cette technique comme une alternative à la radiofréquence. Sa diffusion
semble freinée par son coût et par une efficacité moindre. Ce travail rapporte les résultats
d’une approche réservant la cryoablation au traitement des tachycardies jonctionnelles à haut
risque de bloc auriculo-ventriculaire. 
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Patients et méthodes. — Vingt-six sur 199 patients traités (âge moyen 32,8 ± 15 ans, 15 H) ont subi
une cryoablation pour une tachycardie jonctionnelle. Les indications ont été une voie accessoire
à haut risque de bloc auriculo-ventriculaire (n = 7), une ablation de voie lente difficile avec risque
de bloc auriculo-ventriculaire (n = 7), une récidive après radiofréquence au cours de laquelle est
survenue un bloc auriculo-ventriculaire transitoire (n = 4) ou le jeune âge du patient (n = 8).
Résultats. — Le taux de succès immédiat global a été de 92 %. Aucun bloc auriculo-ventriculaire
permanent n’a été enregistré en radiofréquence ou en cryoablation. Le taux de récidive à
9 ± 10 mois a été de 29 % après cryoablation et de 8,6 % après radiofréquence. Dans le
traitement des tachycardies réciproques nodales, le surcoût du cathéter de cryothérapie a été
évité dans 76,85 % cas. L’utilisation d’un cathéter de cryothérapie et d’un cathéter de
radiofréquence a été nécessaire dans les cas restants.
Conclusion. — Notre étude montre qu’une approche ciblée, réservant la cryoablation à des
patients à risque de bloc auriculo-ventriculaire permanent, est une alternative à une approche
systématique « tout cryothérapie » dans le traitement ablatif des tachycardies jonctionnelles
avec un rapport risque/efficacité favorable chez les patients ayant un risque de BAV.
© 2008 Published by Elsevier Masson SAS.
Introduction
Since more than 15 years, catheter ablation using radiofre-
quency (RF) has been considered as the gold standard for the
management of junctional tachycardia (JT) [1]. This techni-
que has however its limits when the arrhythmogenic subs-
trate is close to structures at risk such as the atrioventricular
(AV) node or the His bundle [2-4]. With the development of
specific catheters, the cryoablation technique has been
developed. This technique appears to be adapted for the
ablation of structures close to the AV conduction pathways.
Its progressive effect permits to assure a definitive lesion
ablation with no risk for the AV conduction pathways [5]. In
consecutive patients with nodal reentrant tachycardia or
tachycardia due to a slow pathway, the efficacy of cryothe-
rapy has been demonstrated, with primary success rates
Figure 1. An example of 2/1 AV block occurring during cryocartography at -30°C, prior to definitive ablation of a slow pathway. 
Resolution of the AV block at cryocartography discontinuation. 
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close to RF [6-8]. However, the number patients enrolled in
these studies was small, and they were seldom randomized
[6-8]. The high rate of long-term recurrence and the material
cost led some medical teams to restrict its use in a selected
population, at risk of conductive blocks or in younger
patients [9]. Others use cryotherapy systematically in order
to avoid any risk of AV block [10]. In this observational and
retrospective study, we report the results of a strategy reser-
ving cryoablation to selected patients at high risk of conduc-
tive blocks or those in the youth (figures 1 and 2).
Methods
From 2004 to 2006, 199 patients benefited from percuta-
neous intracardiac ablation for nodal reentrant tachycar-
dia (NRT, n=121) or related to an accessory pathway
(n=78) in our electrophysiology laboratory. Cryotherapy
has only been used in a selected population. Among these
199 patients, 173 benefited from RF, while 26 benefited
from cryoablation. We included these 26 patients treated
by cryoablation for NRT (n=19) and accessory pathway-
related tachycardia (n=7) in this study.
The selection criteria for the use of cryoablation were:.the presence of an accessory pathway with a high risk
of AV block, documented during EP and after RF
failure;.a slow pathway difficult to ablate, with a risk of AV
block;.a recurrence after a RF procedure, during which a tran-
sient AV block has occurred;.systematically for patients under 25 years of age and fol-
lowing the referent physician’s request.
Figure 2. Flow chart of the reciprocating tachycardia intracardiac ablation procedure.
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The ablation of the accessory pathway was defined at
high risk of AV block in case of mid-septal or para-Hisian
preexcitation [4]. 
The patients were informed of the risks of the procedure
during a prior consultation and signed an informed con-
sent. Patients who were going to benefit from RF were
informed of the possibility of use of cryoablation in case of
high risk of AV block. During the RF procedure, the decision
of switching to the cryoablation technique was taken in
case of failure of ablation of the slow and/or the accessory
pathway and the anatomic proximity of the AV node or the
His bundle (Hisian potential recorded on the ablation
catheter) or in case of occurrence of transient conduction
abnormalities.
The patients under the age of 25 who had the indication
of cryoablation as the first procedure were informed of the
possibility of use of RF in case of cryotherapy failure, upon
their request.
The procedure was performed under sedation with dose
titration of midazolam or propofol. Medical treatment was dis-
continued 4 days prior to the procedure. A quadripolar cathe-
ter was introduced in the femoral vein and positioned in the
right atrium or right ventricle per requirements. A decapolar
catheter was introduced in the right jugular vein and positio-
ned in the right coronary sinus. A conventional ablation cathe-
ter was positioned next to the nodo-Hisian junction. A stan-
dard EP exploration was performed in order to confirm the
diagnosis prior to ablation [11]. A decrement atrial stimulation
using extra-stimuli was performed in to study the refractory
periods, the anterograde and retrograde conduction locations,
and to trigger a reciprocating rhythm. In case of triggering
failure, we used isoprenaline and/or atropine and repeated
the triggering procedure. The diagnosis of NRT or tachycardia
related to an accessory pathway was made after the retro-
grade atrial activity cartography and triggering procedures. An
approach revealing the slow pathway potentials and anatomi-
cal marks permitted the identification of the NRT ablation
site. The ablation site of accessory pathways was determined
after the determination of first-activation of the anterograde
or retrograde pathway. The cryoablation was performed using
a 7F cryocatheter (Cryocath Technologies Inc.) with a 4-mm
(accessory pathway) or 6-mm (NRT) electrode. In a first step,
a cryocartography was performed by lowering the cryoelec-
trode temperature down to –30°C during 60 seconds, in order
to obtain the conduction suppression of the slow or the acces-
sory pathway, in sinus rhythm or reciprocating tachycardia. In
case of failure or the occurrence of AV block, the cryocarto-
graphy was stopped and another site is explored. In case of
success, a cryo-ablation was performed by lowering the tem-
perature down to –70°C during 4 minutes. In case of PR
lengthening, cryoablation was discontinued and a new site
was explored. At the end of procedure, the absence of tachy-
cardia re-induction was verified. In the absence of re-induc-
tion, the procedure was considered primarily successful after
an observation period of 30 minutes. In case of technical diffi-
culties and/or failure, cryoablation could be completed by RF
during the same procedure.
After cryoablation, patients were reassessed in our
center, one month after the procedure, with ECG and
Holter recording or R-Test if needed. We looked systema-
tically for the recurrence of symptoms or arrhythmia.
Four patients were followed by their usual cardiologist.
Patients not seen in our center were systematically
contacted by phone. 
No follow-up lost is reported. 
Quantitative variables are reported as mean ± standard
deviation.
Taking into account that in reentrant nodal tachycardia
the cost of a cryoablation catheter is twice as expensive as
a RF catheter, the additional cost of a systematic cryoa-
blation strategy is calculated as follows: additional cost
= [N-(n+p)] rf (see appendix).
Results
Out of 199 patients, 26 (13%) benefited from cryoablation
(table 1). Among these 26 patients, 19 had a NRT and 7 pre-
sented an accessory pathway-related tachycardia. After EP
exploration, 6 additional patients had a first-intention
cryoablation for mid-septal Kent bundle and one patient for
a para-Hisian Kent bundle. Cryoablation has been perfor-
med straightaway in 8 patients <25 years of age (mean age
=16.8±5 years). Cryoablation has been used at second
intention in 4 patients who had a recurrence after a first RF
complicated by AV block, and during RF procedure in
7 patients because of a high risk of AV block. Thus,
14 patients had a cryoablation alone, 8 had an RF proce-
dure completed by cryoblation and 4 had a cryoablation
completed by RF. 
The mean duration of cryocartogarphy and cryoablation
was 20 ± 19 minutes. The mean number of applications for
cryocartography and cryoablation was 17±10. The mean
ablation temperature was –65°±20°C.
Overall, an immediate success was obtained in 24/
26 patients (92%). Thirteen out of 14 patients (93%) who
had a cryoablation procedure alone were treated success-
fully. The primary success rates were at 100% for those
4 patients when cryoablation had been completed by RF,
Appendix
– The cost of the systematic use of cryoablation (Syst-
Cryo) = Nc, with “N” corresponding to the number of 
patients who should have benefited from ablation and 
“c” the cost of a cryoablation catheter. 
- The cost of a selective approach (SelectCryo) = (N-n) rf 
+ nc + prf with:
rf: cost of RF catheter,
N: the number of patients who should have benefited 
from ablation,
n: number of patients treated by cryoablation,
N-n: number of patients treated by RF,
p: number of patients with cryoablation who would also 
benefit from RF. 
- Taking into account the cost of a cryoablation catheter 
is as twice as expensive as an RF catheter: 2rf 
SelectCryo = (N-n) rf + 2 n rf + prf = [(N-n) + 2n + p] rf = 
(N + n + p) rf, 
SystCryo = 2Nrf
The additional cost of the systematic cryoablation star-
tegy = SystCryo – SelectCryo
= 2Nrf – (N+n+p) rf = (2N–N- n-p) rf = (N-n-p) rf
The additional cost rate = N – n – p /N 
For example, for NRT: 121 – 19 – 9 /121 = 76.85%
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and 87.5% for those 8 patients with RF completed by cryoa-
blation.
A transient AV block is reported in 5 patients (2 first-
degree AVB, 2 cases of 2/1 AVB and 1 complete AVB). No
permanent AV block occured among the 199 patients trea-
ted by RF and/or cryoablation. 
Table 2 reports the characteristics and results of the
subgroups with NRT.
Among 19 patients with NRT, 18 (95%) were treated
successfully. In this subgroup, at follow up, 4/18 patients
had a recurrence. 
Table 3 displays the characteristics and results of
patients who had an accessory pathway-related tachycar-
dia. Among 7 patients in this case, 6 had a primary success
(86%). At follow up, 3/6 had a recurrence of their tachycar-
dia related to a accessory pathway.
The mean follow-up was 9±10 months. Among the
24 patients with primary success, 7 experienced a recur-
rence of their tachycardia. Two patients had a redo RF pro-
cedure and another one had a cryoablation redo procedure.
The remaining patients were treated medically, due to the
conduction risk. The recurrence rate in the RF procedure
was 8.6%.
In case of NRT, cryoablation was only used in 19 out of 121
cases. Among these 121 patients, the cryoablation catheters-
related additional cost avoided is 76.85%. If we take as count
unit the cost of a RF catheter, the additional cost [N-(n+p)] rf
of a systematic use of cryoablation strategy is around
93 times the cost of an RF catheter (see appendix).
Discussion
This observational study shows that cryoablation performed
selectively can be used as a complement method to RF for
treating NRT as well as accessory pathway-related tachycar-
dia. The risk/effectiveness is favorable with a substantial cost
reduction compared to a systematic use of cryoablation.
Because of its efficacy, handiness and cost, RF is the first-line
method in our EP laboratory for the management of junctio-
nal tachycardia. With a higher cost, cryoablation is reserved
for a selected group of patients at high risk of AV block. Some
authors [9] use systematically cryotherapy for the treatment
of NRT as well those related to an accessory pathway, which
is associated to a substantial additional cost. Parallel to this,
no sustained AV block was recorded among our 199 treated
patients, and the primary success rate reported when using
RF is near those reported in the literature, between 91% and
98% [7, 8]. Our approach combining RF and cryoablation at a
same procedure led to satisfying results without any perma-
nent AV block. Our primary success in selected patients for
NRT or accessory pathway-related tachycardia with high risk
Table 1 Patients characteristics and results (total 
population).
Factor Total n = 26
Men/Women (n/n) 15/11
Age years (SD) 32,8 (15)
Age <25 years, n (%) 10 (38)
Cryoapplication, n (SD) 17 (10)
Mean application duration (SD) 10 (19)
Application temperature °C (SD) -65 (20)
Cryoablation ➨ RF n (%) 4 (15)
RF ➨ cryoablation n (%) 8 (30)
Transient AV block, n (%) 5 (19)
Primary success, n (%) 24 (92)
Mid-term recurrence, n (%) 7 (29)
n: number.
RF: radiofrequency.
SD: standard deviation.
Tableau 2 Characteristics and results of patients with
NRT.
Factors NRT n=19
Men/Women (n/n) 10/9
Age years (SD) 34,6 (17)
Age <25 years, n (%) 8 (42)
Cryoapplication, n (SD) 14,5 (8)
Mean application duration (SD) 14 (11)
Application temperature °C (SD) -67 (20)
Cryoablation ➨ RF, n (%) 2 (11)
RF ➨ cryoablation, n (%) 7 (37)
Transient AV block, n (%) 4 (21)
Primary success, n (%) 18 (95)
Mid-term recurrence, n (%) 4 (21)
n: number.
RF: radiofrequency.
SD: standard deviation.
Tableau 3 Characteristics and results of patients with
accessory pathway-related tachycardia.
Factors n = 7
Men/Women (n/n) 5/2
Age years (SD) 28 (10)
Age <25 years, n (%) 2 (29)
Cryoapplication, n (SD) 23 (13)
Mean application duration (SD) 34 (27)
Application temperature °C (SD) -54 (26)
Cryoablation ➨ RF, n(%) 2 (29)
RF ➨ cryoablation, n(%) 1 (14)
Transient AV block, n (%) 1 (14)
Primary success, n (%) 6 (86)
Mid-term recurrence, n (%) 3 (50)
n: number.
RF: radiofrequency.
SD: standard deviation.
154 G. Nadji et al.
of AV block is at 92%. Our approach appears as an alternative
to “systematic RF” or “systematic cryoablation” strategies.
The primary success rates for NRT treated by cryoablation
vary between 91% and 99% in different series [7, 12-14]. When
we consider only those patients with NRT, the primary suc-
cess rate is at 95%. The ablation of septal accessory pathways
by RF technique has a high rate of primary failure compared
to other locations, with a high risk of AV or bundle branch
block [15]. In some series in the literature, the primary suc-
cess rate of cryoablation of these accessory pathways at high
risk of conduction troubles is between 67% and 78% [15, 16].
In our study, the primary success rate in this group is at 86%,
comparable to literature data.
We report no sustained AV block in our series. In the
Topilski et al. report including 901 patients treated for NRT
by RF, 8 cases required a definitive implantation of a pace-
maker [17]. In a prospective multicenter study, Calkins et
al. reported the implantation of a pacemaker in 10 patients
[3]. Conversely to the RF technique which can quickly cause
irreversible lesions, the cryoablation technique makes pro-
gressive and reversible lesions and can therefore limit the
risk of AV block [18-20].
In some series [8, 9], the long-term recurrence rates for
patients with NRT reach 29% to 38%. In our series, the ove-
rall recurrence rate is 29% for those treated by cryoablation
and 8.6% for those treated by RF. In our selected population,
the number and duration of applications is higher than in
other series for all patients, probably due to the elevated
risk of AV block in this subgroup.
Our study presents limitations. It is a small and retrospec-
tive observational series without randomization. Hence,
selection bias might not be excluded. The population presen-
ted corresponds to the beginning of our experience.
Conclusion
Our study demonstrates that a selective approach, reserving
cryoablation for high-risk patients or those at younger age is
efficacious and safe. This is an alternative approach to the
“systematic cryoablation” strategy in the management of
junctional tachycardia, with a favorable risk/efficacy ratio
and reduced cost.
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